Blood & Marrow Transplant Center

Orlando, Florida 32804

0 studies enrolling now · 2 studies all time

What they study most

Acute-graft-versus-host Disease, Graft-versus-host Disease, Graft-versus-host Disease (GVHD)

Studies at this site

• An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant — APPROVED_FOR_MARKETING
• An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD) — Completed